Module A: API Sourcing: India & China
12:00 – 12:30
Analysing latest trends and developments to drive efficiency and effectiveness in global API supply
• Market intelligence: Examining current global shifts in supply and demand
• Analysing vertical integration and CRAMS capabilities
• Debating the ideal sourcing location: Regulated, BRIC and "next wave" emerging market suppliers
• Examining the latest regulatory statistics to assist in making an informed API supply decision
Mike Chase-Ortiz, Sr. Director, Product Strategy, API Intelligence, Thomson Reuters
12:30 – 13:00
Identifying the true cost of using emerging markets: Undertaking a cost/benefit analysis
• Assessing the implications of currency fluctuations when using low cost country manufacturers and how to develop equilibrium in the system
• Examining the hidden costs of working with India and China versus domestic suppliers or outsourcing providers
• Defining rules and clarifying responsibilities to avoid fines and added costs within the partnership
• Exploring the implications of China’s currency revaluation for the pharmaceutical industry
• CASE STUDY
Carol Rose, Development Team Leader, API Strategic Sourcing & Planning, Pfizer
13:00 – 13:30
Developing a robust contract with LCCS partners to reduce risk: Overcoming cultural differences
• Establishing a shared interpretation of standards and regulatory requirements across languages
• Navigating the contractual process and knowing what to define, including appropriate liabilities for key risk areas
• Sharing examples of good contracts
• Improving communication in the partnership: Dealing with language barriers, paperwork and expectations of quality
• Enforcing open-communication to ensure quality control of product and process
Dr. Lori Shen, Director Global Strategic Sourcing, Pfizer
Return to Agenda
|
